[Edaily Starin KIM HYUNSIK Reporter] Kang Kyun-sung (45), a member of the vocal group Noeul, is set to tie the knot with actress Yoo Ha-jin (31). Kang Kyun-sung (left), Yoo Ha-jin (Photo courtesy of S27M Entertainment, Billions)On the 4th, Kang Kyun-sung’s agency, S27M Entertainment, announced, “Kang Kyun-sung will marry Yoo Ha-jin on October 30 at a location in Seoul.” The agency added, “Kang Kyun-sung decided to marry out of deep conviction and love for his fiancée. He plans to continue his activities as both the head of a household and an artist.” The day before, Kang Kyun-sung personally announced his upcoming marriage through his social media channels. He said, “I’ve met someone precious with whom I want to walk through life together, and we’re getting married,” adding, “I’m grateful to ‘Noeulbit’ (his fan club) for their unwavering support and for sharing the precious moments of my life with me. I hope you’ll continue to watch over us with warm hearts and send us your blessings—it will be a great source of strength for me.” The fact that Kang Kyun-sung’s fiancée is Yoo Ha-jin was first revealed in a statement released by his agency that day. The length of their relationship has not been disclosed. Kang Kyun-sung debuted in 2002 as a member of the group “Noeul” and released songs such as “Even Though I Hold On,” “Even If It Hurts, Even If It Hurts,” “Proposal,” and “It Was All You.” Since her debut in 2019, Yoo Ha-jin has appeared in the MBC drama “Spring Night,” the film “Turn: The Street,” and the play “Rental Apartment.”
A virtual creator that doesn’t require a human actor has emerged. There is no pre-written script, nor is there an operator manipulating it in real time. Artificial intelligence (AI) hosts the broadcas…
“When you examine the kidneys of mice with polycystic kidney disease, you can see large cysts. However, after administering Udenafil, a reduction in the size of these cysts was visible even to the nak…
(Graphic: Generative AI)
During the first week of August (August 3–7), SK BIOPHARMACEUTICALS posted its best-ever quarterly earnings, driven by the growth of its new epilepsy drug “cenobamate.” Ad…